CureApp

CureAppCureApp
C

CureApp

Developing digital therapeutics for various medical conditions.

Website
DR 142014InactiveTokyo, Japan
Rate
Advertise here

About

CureApp is a Japanese MedTech company that develops and distributes evidence-based Digital Therapeutics (DTx). They specialize in creating software applications classified as medical devices to address conditions where traditional treatments may be insufficient, focusing on behavioral modification and lifestyle changes. Their offerings include prescription DTx apps for conditions like hypertension, nicotine addiction, NASH, and alcohol dependence.
Frequently asked

What does CureApp do?

CureApp is a Japanese MedTech company that develops and distributes evidence-based Digital Therapeutics (DTx). They specialize in creating software applications classified as medical devices to address conditions where traditional treatments may be insufficient, focusing on behavioral modification and lifestyle changes. Their offerings include prescription DTx apps for conditions like hypertension, nicotine addiction, NASH, and alcohol dependence.

What is CureApp's valuation?

StartupHub estimates CureApp's effective valuation at $356.5M (range $232.4M to $557.8M, 10% confidence), based on comparable companies in the sector.

How much funding has CureApp raised?

CureApp has raised a total of $93M in funding. The most recent round on record is Series G.

Where is CureApp headquartered?

CureApp is headquartered in Tokyo, Japan.

When was CureApp founded?

CureApp was founded in 2014.

What is CureApp's current status?

CureApp's current operating status is: Inactive.

Comments

No comments yet. Be the first to share your take.